Manufacturer record
Talent Healthcare 66-67: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Talent Healthcare 66-67 (Uttarakhand) were declared Not of Standard Quality in August 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: N2309085, Divalproex Sodium Extended-release Tablets IP (exp Aug 2025). CDL, Kolkata (CDSCO lab) found it not of standard quality: Description. Listed in the August 2025 alert.
Records by type
2 records linked to Talent Healthcare 66-67 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Divalproex Sodium Extended-release Tablets IP | Batch N2309085Mfg Sep 2023 · Exp Aug 2025 | DescriptionDescription | CDL, KolkataCDSCO lab | Aug 2025 |
| Divalproex Sodium Extended-release Tablets IP | Batch N2309086Mfg Sep 2023 · Exp Aug 2025 | DescriptionDescription | CDL, KolkataCDSCO lab | Aug 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.